-
EP1273655
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1273655
| EP1273655 - PROCESS FOR PRODUCING RECOMBINANT PROTEIN [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 10.02.2006 Database last updated on 03.06.2024 | Most recent event Tooltip | 10.02.2006 | Application deemed to be withdrawn | published on 29.03.2006 [2006/13] | Applicant(s) | For all designated states Takeda Pharmaceutical Company Limited 1-1, Doshomachi 4-chome, Chuo-ku Osaka / JP | [N/P] |
| Former [2005/01] | For all designated states Takeda Pharmaceutical Company Limited 1-1, Doshomachi 4-chome Chuo-ku Osaka / JP | ||
| Former [2003/02] | For all designated states Takeda Chemical Industries, Ltd. 1-1 Doshomachi 4-chome, Chuo-ku Osaka-shi, Osaka 541-0045 / JP | Inventor(s) | 01 /
YAMADA, Takao 4-3-26, Hitotsuya Matsubara-shi, Osaka 580-0003 / JP | 02 /
TSUJI, Isamu 13-27, Segawa 5-chome Mino-shi, Osaka 562-0045 / JP | 03 /
MATSUI, Hideki 16-1-708, Namiki 4-chome Tsukuba-shi, Ibaraki 305-0044 / JP | [2003/02] | Representative(s) | Lewin, John Harvey TGRD (Europe) Intellectual Property Department 61 Aldwych London WC2B 4AE / GB | [N/P] |
| Former [2003/02] | Lewin, John Harvey Takeda Patent Office, 11-12 Charles II Street London SW1Y 4QU / GB | Application number, filing date | 01917667.6 | 30.03.2001 | [2003/02] | WO2001JP02712 | Priority number, date | JP20000097891 | 30.03.2000 Original published format: JP 2000097891 | [2003/02] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO0175095 | Date: | 11.10.2001 | Language: | EN | [2001/41] | Type: | A1 Application with search report | No.: | EP1273655 | Date: | 08.01.2003 | Language: | EN | The application published by WIPO in one of the EPO official languages on 11.10.2001 takes the place of the publication of the European patent application. | [2003/02] | Search report(s) | International search report - published on: | JP | 11.10.2001 | (Supplementary) European search report - dispatched on: | EP | 17.06.2004 | Classification | IPC: | C12N15/09, C12P21/00, C12P21/02, // C07K14:715, C12P21:02, C12R1:19 | [2003/02] | CPC: |
C07K14/70575 (EP,US);
C12P21/02 (EP,US)
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2003/02] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | RO | Not yet paid | SI | Not yet paid | Title | German: | VERFAHREN ZUR HERSTELLUNG EINES REKOMBINANTEN PROTEINS | [2003/02] | English: | PROCESS FOR PRODUCING RECOMBINANT PROTEIN | [2003/02] | French: | PROCEDE DE PRODUCTION DE PROTEINE DE RECOMBINAISON | [2003/02] | Biological material | This application mentions deposited biological material, check the file for details | Entry into regional phase | 06.09.2002 | Translation filed | 06.09.2002 | National basic fee paid | 06.09.2002 | Search fee paid | 06.09.2002 | Designation fee(s) paid | 06.09.2002 | Examination fee paid | Examination procedure | 09.05.2001 | Request for preliminary examination filed International Preliminary Examining Authority: JP | 06.09.2002 | Examination requested [2003/02] | 10.03.2005 | Despatch of a communication from the examining division (Time limit: M06) | 21.09.2005 | Application deemed to be withdrawn, date of legal effect [2006/13] | 25.10.2005 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2006/13] | Fees paid | Renewal fee | 06.09.2002 | Renewal fee patent year 03 | 15.03.2004 | Renewal fee patent year 04 | 14.03.2005 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO9603432 (CIBA GEIGY AG [CH], et al); | [X] - REYDA SABINE ET AL, "cDNA cloning, bacterial expression, in vitro renaturation and affinity purification of the zinc endopeptidase astacin", BIOCHEMICAL JOURNAL, (19991215), vol. 344, no. 3, ISSN 0264-6021, pages 851 - 857, XP002279353 [X] 1-8 * page 853, column R, paragraphs 1,2 * * page 856, column R, paragraph 2 * DOI: http://dx.doi.org/10.1042/0264-6021:3440851 | [X] - TSUMOTO K ET AL, "Highly efficient recovery of functional single-chain Fv fragments from inclusion bodies overexpressed in Escherichia coli by controlled introduction of oxidizing reagent-application to a human single-chain Fv fragment", JOURNAL OF IMMUNOLOGICAL METHODS, ELSEVIER SCIENCE PUBLISHERS B.V.,AMSTERDAM, NL, (19981001), vol. 219, no. 1-2, ISSN 0022-1759, pages 119 - 129, XP004142546 [X] 1-8 * See whole document and in particular items 2.2, 2.3, 3.1 and 3.2 * DOI: http://dx.doi.org/10.1016/S0022-1759(98)00127-6 | [A] - FRANKEL A E ET AL, "High-Level Expression and Purification of the Recombinant Diphtheria Fusion Toxin DTGM for PHASE I Clinical Trials", PROTEIN EXPRESSION AND PURIFICATION, ACADEMIC PRESS, SAN DIEGO, CA, US, (199906), vol. 16, no. 1, ISSN 1046-5928, pages 190 - 201, XP004441698 [A] 1-8 * page 192, column R, paragraphs 3,4 * DOI: http://dx.doi.org/10.1006/prep.1999.1071 | [A] - STOYAN T ET AL, "RECOMBINANT SOLUBLE HUMAN INTERLEUKIN-6 RECEPTOR. EXPRESSION IN ESCHERICHIA COLI, RENATURATION AND PURIFICATION", EUROPEAN JOURNAL OF BIOCHEMISTRY, BERLIN, DE, (19930801), vol. 216, no. 1, ISSN 0014-2956, pages 239 - 245, XP002047601 [A] 1-8 * page 240, column R, paragraphs 2,3 * DOI: http://dx.doi.org/10.1111/j.1432-1033.1993.tb18138.x | International search | [X]JPH10191989 (TAKEDA CHEMICAL INDUSTRIES LTD); | [Y]WO9803648 (TAKEDA CHEMICAL INDUSTRIES LTD [JP], et al); | [Y]WO9640736 (CELTRIX PHARMA [US]); | [A]WO9829559 (HOECHST MARION ROUSSEL LTD [JP], et al) | [Y] - JEREMY A. HARROP ET AL., "Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growth", THE JOURNAL OF BIOLOGICAL CHEMISTRY, (199810), vol. 273, no. 42, pages 27548 - 27556, XP002947574 DOI: http://dx.doi.org/10.1074/jbc.273.42.27548 | [Y] - MAURI D.N. ET AL., "LIGHT, a new member of the TNF superfamily and lymphotoxin alpha are ligands for herpesvirus entry mediator", IMMUNITY, (1998), vol. 8, no. 1, pages 21 - 30, XP002947575 DOI: http://dx.doi.org/10.1016/S1074-7613(00)80455-0 | [A] - YIFAN ZHAI ET AL., "LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer", J. CLIN. INVEST., (1998), vol. 102, no. 6, pages 1142 - 1151, XP002947576 DOI: http://dx.doi.org/10.1172/JCI3492 |